Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 25,005
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12600955 | Replication-competent recombinant herpes simplex virus type 1 (HSV-1) comprising deletions in the ICP6 and IR regions | 🖼🧊📄§ | 2026-04-14 | 2039-08-09 | 0 | 31 |
| 12600767 | Compounds and methods targeting epiregulin | 🖼🧊📄§ | 2026-04-14 | 2042-05-19 | 0 | 31 |
| 12600778 | Rage antibodies, fragments and uses thereof | 🖼🧊📄§ | 2026-04-14 | 2040-11-02 | 0 | 31 |
| 12599586 | Edaravone suspension for oral administration | 🖼🧊📄§ | 2026-04-14 | 2044-03-26 | 0 | 31 |
| 12599619 | Method of treating blepharitis or conjunctivitis | 🖼🧊📄§ | 2026-04-14 | 2042-05-03 | 0 | 31 |
| 12600711 | Triazacyclododecansulfonamide (TCD)-based protein secretion inhibitors | 🖼🧊📄§ | 2026-04-14 | 2042-05-11 | 0 | 31 |
| 12600771 | Antibody for binding to interleukin 4 receptor | 🖼🧊📄§ | 2026-04-14 | 2043-11-15 | 0 | 31 |
| 12599685 | Tumor stroma imaging agent and preparation method thereof | 🖼🧊📄§ | 2026-04-14 | 2040-10-13 | 0 | 31 |
| 12600715 | Soluble guanylate cyclate activators for treating systemic sclerosis | 🖼🧊📄§ | 2026-04-14 | 2043-11-02 | 0 | 31 |
| 12599637 | Genetically modified Lactobacillus and uses thereof | 🖼🧊📄§ | 2026-04-14 | 2040-02-04 | 0 | 31 |
| 12599677 | Targeted PH sensitive liposomes | 🖼🧊📄§ | 2026-04-14 | 2041-10-04 | 0 | 31 |
| 12599698 | Therapeutic article of manufacture with nanoparticles to promote wound healing and/or antimicrobial infection control | 🖼🧊📄§ | 2026-04-14 | 2042-10-26 | 0 | 31 |
| 12600713 | Crystalline forms of 6-((6,7-dimethoxyquinazolin-4-yl)oxy)-N,2-dimethylbenzofuran-3-carboxamide | 🖼🧊📄§ | 2026-04-14 | 2044-02-27 | 0 | 31 |
| 12599617 | Methods of treating head and neck cancers with hemp extract | 🖼🧊📄§ | 2026-04-14 | 2042-10-26 | 0 | 31 |
| 12600724 | Indole alkaloid and preparation method and use thereof | 🖼🧊📄§ | 2026-04-14 | 2042-11-09 | 0 | 31 |
| 12600765 | Target for anti-cancer and immune-enhancing | 🖼🧊📄§ | 2026-04-14 | 2041-04-09 | 0 | 31 |
| 12600973 | CpG ODN having immunoregulatory function and use thereof | 🖼🧊📄§ | 2026-04-14 | 2041-03-31 | 0 | 31 |
| 12599636 | Treatment of Krabbe disease with umbilical cord blood transplantion (UCBT) and increased galactocerebrosidase (GALC) expression | 🖼🧊📄§ | 2026-04-14 | 2038-01-19 | 0 | 31 |
| 12600959 | PH20 polypeptide variants, formulations and uses thereof | 🖼🧊📄§ | 2026-04-14 | 2045-03-05 | 0 | 31 |
| 12599579 | Compositions and compounds containing ketone bodies and/or ketone body precursors and one or more amino acids | 🖼🧊📄§ | 2026-04-14 | 2045-07-07 | 0 | 31 |
| 12600782 | Anti-PD-L1 and PD-L2 antibody and derivatives and use thereof | 🖼🧊📄§ | 2026-04-14 | 2041-03-30 | 0 | 31 |
| 12600729 | New-type benzazepine fused ring derivative | 🖼🧊📄§ | 2026-04-14 | 2042-03-04 | 0 | 31 |
| 12600758 | Interleukin-2 muteins for the expansion of T-regulatory cells | 🖼🧊📄§ | 2026-04-14 | 2040-08-13 | 0 | 31 |
| 12599596 | Anti-tumor pharmaceutical composition based on immune checkpoint blockade and use thereof | 🖼🧊📄§ | 2026-04-14 | 2044-11-21 | 0 | 31 |
| 12600702 | Crystalline forms of 4-(7-hydroxy-2-isopropyl-4-oxo-4H-quinazolin-3-yl)-benzonitrile and formulations thereof | 🖼🧊📄§ | 2026-04-14 | 2040-02-13 | 0 | 31 |
| 12600725 | Selective GRP94 inhibitors and uses thereof | 🖼🧊📄§ | 2026-04-14 | 2042-01-21 | 0 | 31 |
| 12599676 | Cytotoxic imidazo[1,2-A]pyridine compounds and their use in therapy | 🖼🧊📄§ | 2026-04-14 | 2045-03-06 | 0 | 31 |
| 12599663 | Multivalent peptide conjugates for sustained intra-articular treatment of joint inflammation | 🖼🧊📄§ | 2026-04-14 | 2039-03-08 | 0 | 31 |
| 12600796 | Constructs for chimeric antigen receptors | 🖼🧊📄§ | 2026-04-14 | 2041-09-16 | 0 | 31 |
| 12599656 | Methods for treating HPV-associated diseases | 🖼🧊📄§ | 2026-04-14 | 2039-03-11 | 0 | 31 |
| 12599605 | Uric acid liposomes | 🖼🧊📄§ | 2026-04-14 | 2042-10-25 | 0 | 31 |
| 12599585 | Use of [(1R)-1-(2-chlorophenyl)-2-(tetrazol-2-yl)ethyl] carbamate in combination therapy | 🖼🧊📄§ | 2026-04-14 | 2043-04-13 | 0 | 31 |
| 12600781 | Tumor-targeted agonistic CD28 antigen binding molecules | 🖼🧊📄§ | 2026-04-14 | 2042-11-17 | 0 | 31 |
| 12600766 | Anti-TDP-43 binding molecules and uses thereof | 🖼🧊📄§ | 2026-04-14 | 2040-05-22 | 0 | 31 |
| 12599683 | Mapping nanoparticles | 🖼🧊📄§ | 2026-04-14 | 2042-05-12 | 0 | 31 |
| 12599571 | Method for preparing polydopamine nanomotor using urease, and use of same | 🖼🧊📄§ | 2026-04-14 | 2040-03-10 | 0 | 31 |
| 12599602 | Methods for treating cholestasis | 🖼🧊📄§ | 2026-04-14 | 2044-01-25 | 0 | 31 |
| 12599615 | Use of carotenoids in the treatment of senescence-related diseases | 🖼🧊📄§ | 2026-04-14 | 2040-03-04 | 0 | 31 |
| 12599604 | Application of JAK inhibitor in kidney disease | 🖼🧊📄§ | 2026-04-14 | 2041-12-10 | 0 | 31 |
| 12599584 | Indoline derivatives, compositions comprising them and uses thereof | 🖼🧊📄§ | 2026-04-14 | 2037-01-19 | 0 | 31 |
| 12599597 | Substituted N-benzhydrylacetamide inhibitors of jumanji domain histone demethylases for the treatment of cancer | 🖼🧊📄§ | 2026-04-14 | 2041-03-04 | 0 | 31 |
| 12599653 | Thrombolytic agents for intravascular clots | 🖼🧊📄§ | 2026-04-14 | 2040-10-19 | 0 | 31 |
| 12599626 | Method of obtaining a pharmaceutical agent used for inhibiting the proliferation of tumor cells | 🖼🧊📄§ | 2026-04-14 | 2042-01-10 | 0 | 31 |
| 12599680 | Treatments for ocular neovascularization | 🖼🧊📄§ | 2026-04-14 | 2045-08-14 | 0 | 31 |
| 12599624 | Biodegradable lung sealants | 🖼🧊📄§ | 2026-04-14 | 2042-08-30 | 0 | 31 |
| 12599599 | Anti-inflammatory, anti-cancer, and anti-angiogenic compounds, pharmaceutical compositions, and methods of making and using thereof | 🖼🧊📄§ | 2026-04-14 | 2043-07-20 | 0 | 31 |
| 12599654 | Immunogenic peptide fragments of metalloprotease ADAMTS-7 and uses thereof in anti-atherosclerosis and related diseases | 🖼🧊📄§ | 2026-04-14 | 2040-08-20 | 0 | 31 |
| 12599634 | Nerve guidance conduit comprising neural crest stem-like cells and/or Schwann cell precursor-like cells and methods of making and using the same | 🖼🧊📄§ | 2026-04-14 | 2042-09-22 | 0 | 31 |
| 12600783 | Anti-New York esophageal squamous cell carcinoma 1 (NY-ESO-1) antigen-binding proteins and methods of use thereof | 🖼🧊📄§ | 2026-04-14 | 2040-07-02 | 0 | 31 |
| 12600727 | Treatment of infections of toxoplasma gondii and closely related parasites | 🖼🧊📄§ | 2026-04-14 | 2039-09-18 | 0 | 31 |